American Chemistry Council [Center for the Polyurethanes Industry, Diisocyanates Panel, and Aliphatic Diisocyanates Panel] (ACC)
(signed September 13, 2017)
Through the Alliance, OSHA and ACC will work together to provide members, occupational physicians, stakeholders, and others within the polyurethanes value chain with information, guidance, and access to training resources that will help them protect the health and safety of workers, particularly by: 1) illustrating methods for reducing and preventing exposure to aliphatic and aromatic diisocyanates (MDI, TDI, HDI, HMDI, and IPDI); 2) providing a better understanding of the health issues, routes of exposure, and medical surveillance/clinical evaluation techniques related to diisocyanates; and 3) understanding the rights of workers and the responsibilities of employers under the Occupational Safety and Health Act (OSH Act). The goals of the Alliance include:
Raising Awareness of OSHA’s Rulemaking and Enforcement Initiatives:
- To share information on OSHA’s National Emphasis Programs, the Regulatory Agenda, and opportunities to participate in the rulemaking process.
- To share information on occupational safety and health laws, standards, and guidance resources, including the rights and responsibilities of workers and employers.
Training and Education:
- To conduct effective web-based training to educate employers and workers on safe use and handling when working with diisocyanates, specifically potential routes of exposure to downstream users that will be shared with OSHA personnel and other industry safety and health professionals and incorporate learning evaluations to ensure training is effective.
Outreach and Communication:
- To develop information on the recognition and prevention of workplace hazards by developing medical surveillance guidance and workplace guidance documents on safe use and handling to prevent both inhalation and dermal exposure when working with diisocyanates and to develop ways of communicating such information (e.g., print and electronic media, electronic assistance tools, and OSHA’s and the ACC’s websites) to employers, workers in the industry, and health care professionals.
- To speak, exhibit, or appear at OSHA or ACC conferences, local meetings, or other regional events.
- To promote, through seminars and workshops, industry-wide use of medical surveillance programs, encouraging employers to develop new or enhance existing performance programs including the development of Safety and Health Management Systems.
Deputy Assistant Secretary Loren Sweatt, USDOL-OSHA (seated, center), with representatives of ACC and OSHA at the Alliance signing ceremony on September 13, 2017.
Related Documents
Alliance Agreements
- Agreement signed September 13, 2017.
Alliance Annual Reports
- Alliance Annual Report FY2018, Office of Outreach Services and Alliances.
Products and Resources
Alliance Program Participant Developed Products
- Personal Protective Equipment: General Recommendations for Automotive Refinishing Coating Applications. (PDF) (2018, March). Through the OSHA Alliance Program, the American Chemistry Council’s Aliphatic Diisocyanates Panel developed an infographic that provides personal protective equipment recommendations for the automotive refinish market.
- Medical Screening and Surveillance for Workers Potentially Exposed to Diisocyanates: A Guide for Workers. (PDF) (2019, February) Through the OSHA Alliance Program, the American Chemistry Council’s Aliphatic Diisocyanates Panel developed a guidance document as a resource for workers that specifically addresses potential adverse health effects due to diisocyanates exposure. The document also provides information on the role of medical screening and surveillance in preventing these effects.
- Medical Screening and Surveillance for Workers Potentially Exposed to Diisocyanates: A Guide for the Employer. (PDF) (2019, February) Through the OSHA Alliance Program, the American Chemistry Council’s Aliphatic Diisocyanates Panel developed a guidance document as a resource for workers that specifically addresses potential adverse health effects due to diisocyanates exposure. The document also provides information on the role of medical screening and surveillance in preventing these effects.